Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 9Gynecologic 3Breast 3Lymphoid 1Classical hematology 1

Conditions

Ovarian Neoplasms 13Fallopian Tube Neoplasms 5Carcinoma, Ovarian Epithelial 5Lung Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Seminoma 2Neutropenia 2Endodermal Sinus Tumor 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Teratoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Adenosquamous Carcinoma 1Endometrial Adenocarcinoma 1Dysgerminoma 1Communicable Diseases 1Colorectal Neoplasms 1Carcinoma, Embryonal 1

Interventions

pembrolizumab 19Paclitaxel 10Carboplatin 10Magnetic Resonance Spectroscopy 9Docetaxel 9Cyclophosphamide 9Specimen Handling 8Cisplatin 8Gemcitabine 7Drug Therapy 7sargramostim 6Pemetrexed 6Nivolumab 6fludarabine 5aldesleukin 5Trastuzumab 5Bevacizumab 5Taxes 4Fluorouracil 4Blood Specimen Collection 4Amifostine 4veliparib 3pegfilgrastim 3Topotecan 3Irinotecan 3IFL protocol 3Fluorodeoxyglucose F18 3Etoposide 3Early Intervention, Educational 3tariquidar 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lung Neoplasms × pegfilgrastim × Gynecologic × Clear all
NCT02649673 2023-12-05

LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

SCRI Development Innovations, LLC

Phase 1 Terminated
34 enrolled
GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT00117442 2013-05-13

A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood

Amgen

Phase 2 Completed
61 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Amgen

Phase 4 Completed
852 enrolled
BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡